ArticleDiabetes & vascular disease research
MiR-143-3p serves as a novel biomarker for diabetic cardiomyopathy and is involved in regulating high glucose-induced cardiomyocyte injury.
Zhengnan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.